Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Titan Pharmaceuticals Inc
TTNP
Healthcare
Titan Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura offers continuous drug delivery and consists of a small, semi-rigid, flexible implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The...
resulting product is a solid matrix implant that is placed subdermally, normally in the inside part of the upper arm, in a brief procedure using a local anesthetic and is removed in a similar manner at the end of the treatment period. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus. Its product development programs are in non-clinical stages of development.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:TTNP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Sep 05, 2024 8:45pm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI
Breaking News: $TTNP SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, CFB, TTNP, DFS on Behalf of ShareholdersNEW YORK, NY / ACCESSWIRE / September 5, 2024 / Halper Sadeh LLC, an investor
...more
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Aug 22, 2024 3:00pm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYT
NEWS: $TTNP SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYTH, VGR, TTNP on Behalf of ShareholdersNEW YORK, NY / ACCESSWIRE / August 22, 2024 / Halper Sadeh LLC, an investor rights law
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(9)
•••
MikeTester
X
View Profile
View Bullboard History
Post by
MikeTester
on Aug 03, 2024 4:01pm
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP): Navigating the Ch
https://beyondspx.com/2024/08/02/titan-pharmaceuticals-inc-nasdaqttnp-navigating-the-challenges-of-a-transitioning-pharmaceutical-company/
(0)
•••
Peng26
X
View Profile
View Bullboard History
Post by
Peng26
on Apr 13, 2023 5:40am
FSD Pharma Inc is about to launch this breakthrough product
Kevin Harrington Speaks about FSD Pharma
(0)
•••
KennyH
X
View Profile
View Bullboard History
Post by
KennyH
on Apr 13, 2023 3:26am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
(0)
•••
KennyH
X
View Profile
View Bullboard History
Post by
KennyH
on Jul 15, 2022 9:07pm
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent
(0)
•••
KennyH
X
View Profile
View Bullboard History
Post by
KennyH
on Jun 03, 2022 4:47am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
FSD Pharma ready to proceed with Phase 2 clinical trial of
...more
(0)
•••
KennyH
X
View Profile
View Bullboard History
Post by
KennyH
on Jun 02, 2022 12:03am
FSD Pharma Files Investigational New Drug Application “IND”
(0)
•••
KennyH
X
View Profile
View Bullboard History
Post by
KennyH
on May 11, 2022 12:36am
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
(0)
•••
KennyH
X
View Profile
View Bullboard History
Post by
KennyH
on May 03, 2022 10:12pm
Lucid-MS for Multiple Sclerosis Treatment
(0)
•••
KennyH
X
View Profile
View Bullboard History
Post by
KennyH
on Apr 26, 2022 1:27am
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
(0)
•••
KennyH
X
View Profile
View Bullboard History
Post by
KennyH
on Apr 19, 2022 1:12am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings
...more
(0)
•••
KennyH
X
View Profile
View Bullboard History
Post by
KennyH
on Apr 09, 2022 1:41am
FSD: Cancellation of Certain Shares Issued to Former CEO
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)
...more
(0)
•••
KennyH
X
View Profile
View Bullboard History
Post by
KennyH
on Apr 07, 2022 11:56am
FSD Pharma Issues Corporate Updates
FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to
...more
(0)
•••
KennyH
X
View Profile
View Bullboard History
Post by
KennyH
on Apr 06, 2022 1:19am
iMining: First Hospital Foundation in Decentraland Metaverse
iMining Enters into Agreement for the First-Ever Hospital Foundation to Be Launched in the Decentraland Metaverse Vancouver, British Columbia--(Newsfile Corp.) - iMining Technologies Inc
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >